Skip to main content

Table 3 Demographic and clinical characteristics of patients with K. pneumoniae blood stream infections stratified by survivors versus non-survivors

From: Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study to translate to patient outcomes

Variable

Survived (n = 63)

Died (n = 12)

p-value

Age (mean, SD)

58.8 (16.6)

64 (11.7)

0.30

Gender, female

32 (50.8)

8 (66.7)

0.36

Modified APACHE II score (mean, SD)

10.6 (4.3)

13.2 (4.9)

0.07

Prior hospitalization

29 (46)

11 (91.7)

<0.01

Neutropenic

2 (3.2)

0 (0)

0.99

Renal dysfunction

7 (11.1)

6 (50)

<0.01

Liver dysfunction

6 (9.5)

1 (8.3)

0.99

Diabetes

7 (11.1)

4 (33.3)

0.07

Current immunosuppressive therapy

10 (15.9)

2 (16.7)

0.99

LOS prior to positive culture (median, IQR)

1 (1–1)

10.5 (2.5-23)

<0.01

Time to directed therapy (hrs) (median, IQR)

6 (3–15.5)

0 (0–5.25)

<0.01

K. pneumoniae cultured from >1 site

24 (38.1)

6 (50)

0.44

Total days of antibiotics post infection (median, IQR)

7 (4–14)

9 (5–15.5)

0.56

KPC(+) status

10 (15.9)

5 (41.7)

0.055

  1. Note: Data are no. (%) of patients unless otherwise indicated.
  2. KPC = Klebsiella pneumoniae producing carbapenemase, APACHE = Acute Physiology and Chronic Health Evaluation, LOS = length of stay, SD = standard deviation, IQR = interquartile range.